BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2903653)

  • 21. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 22. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celiprolol and verapamil in the treatment of essential hypertension.
    McInnes GT; McLenachan JM; Henderson E; Herrick AL; Dargie HJ
    Am Heart J; 1988 Nov; 116(5 Pt 2):1437-8. PubMed ID: 2903656
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
    Norris RJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Celiprolol in the treatment of chronic stable angina].
    Román O; Cuevas G; Martínez D; Vargas W
    Rev Med Chil; 1991 Jan; 119(1):50-5. PubMed ID: 1688095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
    Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
    Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI; Jennings AA; Bateman ED; Opie LH
    Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing angina with beta blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Oct; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.